Question explored with the scientific record
Conversation so far
- 1 Damiana leaf tea
- 2 What doses or active compounds in damiana could reach the brain?
Answered on this page ↓
What doses or active compounds in damiana could reach the brain?
Damiana's own compounds have never been measured in human blood or brain here. The only damiana record is a lab dish, not a body.
The one damiana study in front of me isolated pinocembrin, acacetin, apigenin 7-glucoside and Z-echinacin and measured how strongly they block aromatase, an enzyme, in a test tube [4]. That tells you the molecules exist and are biologically active. It tells you nothing about how much survives the gut, enters the blood, or crosses into the brain. No dose, no plasma level, no brain measurement.
The closest thing to a brain-relevant number comes from other plants. Flavonoid glycosides like these absorb poorly: hyperin reached only about 1 in 100 of the dose in mouse blood [2], and quercetin in dogs was about 4 in 100 bioavailable, with most of what circulates being conjugated, meaning chemically tagged and altered [3]. A niosomal ginkgo formulation did push measurable extract into rat brain [1], but that is an engineered carrier, not a tea.
| Compound (source plant) | What was measured | Value |
|---|---|---|
| Pinocembrin (damiana) | Aromatase inhibition, test tube | IC50 10.8 µM [4] |
| Acacetin (damiana) | Aromatase inhibition, test tube | IC50 18.7 µM [4] |
| Hyperin (other plant) | Oral bioavailability, mouse | 1.2% [2] |
| Quercetin (other plant) | Oral bioavailability, dog | about 4% [3] |
So the honest answer to "what dose reaches the brain" is that nobody has measured it for damiana. The chemistry says the likely actors are pinocembrin and acacetin [4], and the absorption data from cousin flavonoids says most of an oral dose never makes it into blood intact [2][3]. A tea delivers a small, variable amount on top of that.
My call: no human or animal study here shows any damiana compound reaching the brain, and the flavonoid absorption data makes a large brain dose unlikely from tea. Confidence: low, because the pharmacokinetic study that would settle it has not been done in front of me.
Sources used 4
-
Development of a novel niosomal system for oral delivery of Ginkgo biloba extract
This study developed a novel niosomal system for the oral delivery of Ginkgo biloba extract, demonstrating improved bioavailability and targeted delivery to the brain compared to conventional tablets.
DOI: 10.2147/IJN.S37984 -
Simultaneous quantification of hyperin, reynoutrin and guaijaverin in mice plasma by LC‐MS/MS: application to a pharmacokinetic study
This study developed and validated a sensitive LC-MS/MS method for the simultaneous quantification of hyperin, reynoutrin, and guaijaverin in mouse plasma, revealing poor oral absorption and low bioavailability of these flavonoid glycosides, with significant pharmacokinetic inte…
DOI: 10.1002/bmc.3660 -
Oral bioavailability of quercetin from different quercetin glycosides in dogs
In beagle dogs, oral quercetin absolute bioavailability was about 4%; isoquercitrin increased relative bioavailability versus aglycone, whereas rutin absorption was delayed but rutin bioavailability was not lower than aglycone.
DOI: 10.1017/s000711451000053x -
Anti-aromatase activity of the constituents from damiana (Turnera diffusa)
This study investigates the anti-aromatase and estrogenic activities of constituents isolated from the leaves of Turnera diffusa, revealing that the methanolic extract and specific compounds like pinocembrin and acacetin significantly inhibit aromatase activity and exhibit estro…
DOI: 10.1016/j.jep.2008.09.016